Natixis Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-12,111
Closed -$297K 1011
2016
Q3
$297K Sell
12,111
-114
-0.9% -$2.95K ﹤0.01% 974
2016
Q2
$246K Buy
+12,225
New +$346K ﹤0.01% 964
2015
Q4
Sell
-10,729
Closed -$1.91M 981
2015
Q3
$1.91M Sell
10,729
-5,535
-34% -$1.29M 0.03% 611
2015
Q2
$3.61M Sell
16,264
-2,804
-15% -$622K 0.06% 445
2015
Q1
$3.79M Sell
19,068
-15,548
-45% -$2.76M 0.07% 451
2014
Q4
$4.95M Sell
34,616
-1,373
-4% -$185K 0.09% 334
2014
Q3
$4.72M Sell
35,989
-30,881
-46% -$3.68M 0.09% 331
2014
Q2
$8.43M Buy
66,870
+9,430
+16% +$1.2M 0.12% 270
2014
Q1
$7.57M Sell
57,440
-2,792
-5% -$382K 0.12% 297
2013
Q4
$7.07M Sell
60,232
-1,869
-3% -$205K 0.12% 289
2013
Q3
$6.48M Buy
62,101
+3,689
+6% +$359K 0.12% 293
2013
Q2
$5.03M Buy
+58,412
New +$4.6M 0.1% 336

Other funds holding BHC

Natixis Advisors's BHC Position: Q4 2016 in Review

Natixis Advisors sold out of Bausch Health (BHC) in Q4 2016, closing a stake of 12,111 shares — an estimated $297K sold.

Natixis Advisors first reported a position in BHC in Q2 2013 and held it in 12 quarters. The position peaked at $8.43M in Q2 2014. 315 funds tracked by Wall St. Rank hold BHC as of Q4 2016.

  • Natixis Advisors reported no remaining Bausch Health position as of Q4 2016 after selling out during the quarter.
  • Natixis Advisors sold 12,111 Bausch Health shares in Q4 2016, an estimated $297K.
  • Natixis Advisors first reported a position in Bausch Health in Q2 2013 and held it in 12 quarters.
  • Natixis Advisors's Bausch Health position peaked at $8.43M in Q2 2014.
  • 315 funds tracked by Wall St. Rank held Bausch Health as of Q4 2016.

Based on Natixis Advisors's 13F filing for Q4 2016, filed 7 Feb 2017.